The IQ Consortium marks a decade of impactful innovation of collaboration through a network of pharmaceutical companies driving change for the bio/pharmaceutical industry.
Margaret M. Faul
Advertisement
Margaret M. Faul is vice-president, Drug Product Technologies, Process Development, Amgen.
Articles by Margaret M. Faul
Advertisement
Latest Updated Articles
Viewpoint: Precompetitive Collaboration Drives Pharma Industry InnovationPublished: October 15th 2020 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
From Parm to Pharm: Avantor, p-Chip Bring COI Compliance to Clinical Consumables
2
Ask the Expert: Commenting on Draft Regulations
3
A-TEEM: A Novel, Powerful Tool for Evaluating and Monitoring Cell Culture Media
4
Challenges, Innovations, and Future Outlook of Biologics Formulations
5
